Cargando…

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus

BACKGROUND: Elevated triglycerides or triglyceride-rich lipoproteins are an additional cause of cardiovascular (CV) disease. Given that patients with systemic lupus erythematosus (SLE) have a high prevalence of premature CV disease and show an altered lipid profile, our objective was to study whethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quevedo-Abeledo, Juan Carlos, Martín-González, Candelaria, Ferrer-Moure, Carmen, de Armas-Rillo, Laura, Hernandez-Hernandez, Maria Vanesa, González-Gay, Miguel Á., Ferraz-Amaro, Iván
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124762/ https://www.ncbi.nlm.nih.gov/pubmed/35615358 http://dx.doi.org/10.3389/fimmu.2022.827355

Ejemplares similares

Apolipoprotein C-III in patients with systemic lupus erythematosus
por: Martín-González, Candelaria, et al.
Publicado: (2022)

SCORE2 versus SCORE in patients with systemic lupus erythematosus
por: Quevedo-Abeledo, Juan Carlos, et al.
Publicado: (2022)

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus
por: Sánchez-Pérez, Hiurma, et al.
Publicado: (2020)

Blood Composite Scores in Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Júlia, et al.
Publicado: (2023)

Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2023)

Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
por: de Armas-Rillo, Laura, et al.
Publicado: (2022)

Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Julia, et al.
Publicado: (2023)

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
por: García-González, María, et al.
Publicado: (2023)

Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus
por: Merino de Paz, Nayra, et al.
Publicado: (2023)

Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
por: Fernández-Cladera, Yolanda, et al.
Publicado: (2023)

Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
por: García-González, María, et al.
Publicado: (2023)

Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease
por: Rodríguez-Hernández, Orvelindo, et al.
Publicado: (2023)

Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity
por: González-Sierra, Marta, et al.
Publicado: (2023)

Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
por: Hernández-Camba, Alejandro, et al.
Publicado: (2022)

Cytokine disturbances in systemic lupus erythematosus
por: Jacob, Noam, et al.
Publicado: (2011)

The Ratio of Monocytes to HDL-Cholesterol Is Associated with Cardiovascular Risk and Insulin Resistance in Patients with Rheumatoid Arthritis
por: Romo-Cordero, Alejandro, et al.
Publicado: (2023)

Metabolic Disturbances Associated with Systemic Lupus Erythematosus
por: Wu, Tianfu, et al.
Publicado: (2012)

Electrocardiographic disturbances in children with systemic lupus erythematosus
por: AlTwajery, Mohammed, et al.
Publicado: (2018)

Disturbances of apoptotic cell clearance in systemic lupus erythematosus
por: Shao, Wen-Hai, et al.
Publicado: (2011)

Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosus
por: Contreras-Haro, Betsabe, et al.
Publicado: (2019)

The Performance of Vascular Age in the Assessment of Cardiovascular Risk of Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2020)

Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Leukocyte Beta-Catenin Expression Is Disturbed in Systemic Lupus Erythematosus
por: Orme, Jacob J., et al.
Publicado: (2016)

Triglycerides as Biomarker for Predicting Systemic Lupus Erythematosus Related Kidney Injury of Negative Proteinuria
por: Si, Mingjun, et al.
Publicado: (2022)

Systemic lupus Erythematosus and geomagnetic disturbances: a time series analysis
por: Stojan, George, et al.
Publicado: (2021)

Orbital myositis in systemic lupus erythematosus
por: Hernandez Fustes, Otto J.
Publicado: (2021)

Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus
por: Perez-Hernandez, Javier, et al.
Publicado: (2015)

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363
por: Ferraz-Amaro, Iván, et al.
Publicado: (2022)

SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus
por: Diószegi, Ágnes, et al.
Publicado: (2023)

Evidence of New Risk Genetic Factor to Systemic Lupus Erythematosus: The UBASH3A Gene
por: Diaz-Gallo, Lina-Marcela, et al.
Publicado: (2013)

Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline
por: Mok, Chi Chiu
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o0ihbk0atsdairrhm62omj6mp4